SCHEMBL24518896

SCHEMBL24518896

CC1(C)c2ccccc2-c2c1ccc1oc3cc(-c4c5ccccc5c(-c5ccc6oc7ccc8oc9ccccc9c8c7c6c5)c5ccccc45)ccc3c21

nearest known ligand 0.33

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HCRTR1 O43613 1/20 0.33
HSP90AA1 P07900 1/20 0.32
HSP90AB1 P08238 1/20 0.32
WEE1 P30291 2/20 0.32
AHR P35869 1/20 0.31
L3MBTL1 Q9Y468 1/20 0.31
PGR P06401 1/20 0.31
MEN1 O00255 2/20 0.31
MAPT P10636 2/20 0.31
KMT2A Q03164 2/20 0.31
KDM4E B2RXH2 1/20 0.31
ALDH1A1 P00352 1/20 0.31
HPGD P15428 1/20 0.31
CASP3 P42574 1/20 0.31
SENP7 Q9BQF6 1/20 0.31
SENP6 Q9GZR1 1/20 0.31
CA1 P00915 1/20 0.30
CA2 P00918 1/20 0.30
ALK Q9UM73 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24518895 0.98 HCRTR1 (0.34) HCRTR1HSP90AA1HSP90AB1WEE1AHR
SCHEMBL24519023 0.98 WEE1 (0.33) HCRTR1HSP90AA1HSP90AB1WEE1AHR
SCHEMBL24519001 0.96 HSP90AA1 (0.34) HSP90AA1HSP90AB1WEE1L3MBTL1PGR
SCHEMBL24519111 0.94 HCRTR1 (0.31) HCRTR1WEE1
SCHEMBL24518910 0.93 WEE1 (0.35) HSP90AA1HSP90AB1WEE1AHRL3MBTL1
SCHEMBL24519116 0.92 WEE1 (0.30) WEE1
SCHEMBL24519025 0.90 WEE1 (0.31) WEE1
SCHEMBL26750744 0.90 WEE1 (0.38) HSP90AA1HSP90AB1WEE1L3MBTL1CASP3
SCHEMBL24519104 0.89 ALOX5 (0.36) HSP90AA1HSP90AB1
SCHEMBL24519119 0.89

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11367838-B2 Anthracene derivative and organic light-emitting device comprising same LG CHEM, LTD. (KR) 2022-06-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11367838-B2 Anthracene derivative and organic light-emitting device comprising same CCNL2, CRY1, CYP2S1 HCRTR1 1370/4885HSP90AA1 3409/4885HSP90AB1 3367/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.